Company & Sponsor Intelligence
UConn Health
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed5
Countries1
Therapeutic footprint
alzheimersdepressionparkinsonsptsdsubstance_use
Indexed studies
NCT02365051Translation of COPE for Publicly-Funded Home Care Clients and Their Families
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT02502929Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians
depression · United StatesNA
depression · United StatesNA
NCT07009977Project BrEAtHe: A Culturally Tailored MBSR Intervention for Young Adult Black Men
ptsd · United StatesNA
ptsd · United StatesNA
NCT00606853Enhanced and Attendance-based Prize CM in Community Settings
substance_use · United StatesNA
substance_use · United StatesNA
NCT00387855An Evaluation of the SOS (Suicide Prevention) Program
depression · United StatesNA
depression · United StatesNA
NCT06170866Peer Partners to Improve Physical Activity in Older Latino and Latina Adults With Parkinson's Disease.
parkinsons · United StatesNA
parkinsons · United StatesNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →